Legend Biotech Corporation (FRA:9LB)

Legend Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,976	3,420	5,766	9,896	7,819	6,309
Market Cap Growth	-44.58%	-40.69%	-41.73%	26.55%	23.93%	106.63%
Enterprise Value	2,377	2,924	4,930	8,898	7,200	5,815
Last Close Price	15.30	18.50	31.60	54.00	46.40	41.60

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PS Ratio	2.67	3.90	9.52	38.37	71.42	104.26
PB Ratio	2.76	4.01	5.74	8.74	11.23	9.37
P/TBV Ratio	2.76	4.01	5.74	8.77	11.28	9.43

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	2.14	3.34	8.14	34.50	65.76	96.08

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.23	0.41	0.34	0.26	0.38	0.16
Net Debt / Equity Ratio	-0.56	-0.53	-0.74	-0.78	-1.00	-0.99
Net Debt / EBITDA Ratio	16.50	4.21	2.62	1.89	1.66	1.97
Net Debt / FCF Ratio	5.64	4.15	4.88	2.37	3.34	3.16
Asset Turnover	0.74	0.61	0.36	0.18	0.10	0.08
Inventory Turnover	14.32	14.60	10.83	9.68	10.80	-
Quick Ratio	2.88	1.88	4.49	6.77	3.59	4.11
Current Ratio	3.04	1.96	4.62	6.92	3.69	4.14
Return on Equity (ROE)	-8.08%	-29.06%	-15.45%	-51.94%	-59.11%	-59.19%
Return on Assets (ROA)	-1.92%	-5.01%	-10.84%	-20.76%	-23.37%	-26.75%
Return on Invested Capital (ROIC)	-9.91%	-37.10%	-113.02%	-384.74%	-9433.71%	-770.35%
Return on Capital Employed (ROCE)	-3.90%	-12.40%	-21.90%	-32.40%	-44.30%	-44.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-2.69%	-7.39%	-2.96%	-4.74%	-5.34%	-5.62%
FCF Yield	-3.58%	-3.21%	-2.65%	-3.78%	-2.66%	-3.35%
Buyback Yield / Dilution	-0.92%	-0.80%	-3.84%	-10.71%	-12.91%	-19.21%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 17, 2026

Data Sources Report a data error